What Is Alpha-Arbutin: Chemical Structure and Physicochemical Properties
Alpha-arbutin, chemically named 4-Hydroxyphenyl-α-D-glucopyranoside, is a glycosidic compound formed by linking one molecule of hydroquinone (p-dihydroxybenzene) with one molecule of glucose via an α-configuration glycosidic bond. Compared with beta-arbutin, which is widely found in natural plants, the only difference lies in the spatial configuration of the glycosidic bond—yet the performance difference is significant.
Parameter | Value |
|---|---|
CAS Number | 84380-01-8 |
EINECS Number | 440-470-8 |
Molecular Formula / Weight | C₁₂H₁₆O₇ / 272.25 |
Appearance | White crystalline powder |
Melting Point | 202–207 °C |
Water Solubility | Approx. 151 g/L (20–25 °C); readily soluble in water, slightly soluble in ethanol, insoluble in non-polar solvents |
Specific Optical Rotation [α] D²⁰ | +175° ~ +185° (key indicator for distinguishing α/β configuration) |
Optimal pH Range | 3.5–6.6 |
R&D Notes: Alpha-arbutin has good water solubility and can be incorporated directly into the aqueous phase at room temperature or under mild heating (<70 °C). Specific optical rotation is a critical quality control item for determining configurational purity; suppliers should provide rotation data with each batch.
Whitening Mechanism: Competitive Tyrosinase Inhibitor
In the melanin synthesis pathway, tyrosinase is the rate-limiting enzyme: it catalyzes the conversion of L-tyrosine to L-DOPA, which is then oxidized to dopaquinone, ultimately producing eumelanin/pheomelanin through a series of reactions. The molecular structure of alpha-arbutin is highly similar to the natural substrate tyrosine (hydroquinone core + glucose), allowing it to reversibly and competitively bind to the active site of tyrosinase, blocking substrate access and inhibiting melanin synthesis at the upstream stage.
Key Mechanistic Data (from literature):
Inhibition constant Ki ≈ 0.2 mM against human tyrosinase, with reversible competitive inhibition;
Against mouse melanoma tyrosinase, alpha-arbutin is approximately 10 times more potent than beta-arbutin (Sugimoto 2003);
Unlike hydroquinone, alpha-arbutin does not suppress tyrosinase mRNA expression nor damage melanocyte viability, and therefore lacks the long-term risks associated with hydroquinone, such as cytotoxicity and ochronosis.
R&D Notes: Alpha-arbutin inhibits the "melanin synthesis" step; for existing pigmentation, it should be combined with keratolytic ingredients. Its mild, reversible inhibition profile also means that effects are reversible upon discontinuation, offering a better safety profile than hydroquinone and its derivatives.
Alpha-Arbutin vs. Beta-Arbutin vs. Deoxyarbutin
Comparison Dimension | Alpha-Arbutin | Beta-Arbutin | Deoxyarbutin |
|---|---|---|---|
Structure | Hydroquinone + α-glycosidic bond | Hydroquinone + β-glycosidic bond | Deglycosylated derivative |
Primary Source | Enzymatic synthesis | Natural extraction (bearberry leaves, etc.) | Chemical synthesis |
Tyrosinase Inhibition Potency | ~10× that of beta | Baseline | ~10× that of beta; 1.5× that of hydroquinone (in vitro IC50 ≈ 0.9 μM) |
Thermal Stability | No decomposition at 100 °C | Slight decomposition above 60 °C | Poor |
pH Stability | Essentially no decomposition at pH 5.2–8.0 | Degrades under certain conditions | Requires strict control |
Hydroquinone Release Risk | Low (trace levels) | Relatively higher; concerns over hydrolytic release of hydroquinone | Attention to intermediate impurities |
EU Limit | Face cream ≤2%; body lotion ≤0.5% | Face cream ≤7% | No unified limit |
Cost | High | Low | Medium |
R&D Notes: The choice among the three is essentially a "potency–stability–cost" triangle. Alpha-arbutin offers the best overall performance and is suitable as a core whitening ingredient; beta-arbutin offers high cost-effectiveness for mass-market products but requires enhanced stability design; deoxyarbutin has strong in vitro potency but weaker stability and regulatory support, requiring careful evaluation.
Key Efficacy and Safety Data
Stability (raw material grade): DSM long-term stability data show that alpha-arbutin pure powder stored at 25 °C and 40 °C for 36 months maintains purity with hydroquinone content consistently below the limit of quantification (LOQ 3 ppm);
Photostability: In water/methanol solutions exposed to normal sunlight for 12 months (≥8 hours daily), no hydroquinone was detected, with no evidence of photocatalytic degradation;
Formulation stability: In a 2% alpha-arbutin O/W emulsion, the addition of a citrate buffer system reduced hydroquinone from 13–18 ppm in freshly prepared product to 1–3 ppm, significantly suppressing hydroquinone formation; unbuffered formulations stored at 40 °C for 13 weeks showed hydroquinone rising to approximately 50 ppm (maximum 79 ppm);
Safety conclusion: The European Commission's Scientific Committee on Consumer Safety (SCCS) considers alpha-arbutin safe at concentrations of ≤2% in face creams and ≤0.5% in body lotions, and safe when both products are used simultaneously.
Global Regulatory and Compliance Key Points
Mainland China：Listed in the Inventory of Existing Cosmetic Ingredients in China (2021 Edition); not included in prohibited, restricted, or permitted lists; no maximum concentration limit; in August 2023, the National Medical Products Administration (NMPA) revised and published the Testing Methods for 4 Ingredients Including Alpha-Arbutin in Cosmetics; skin-lightening products are classified as special cosmetics, and efficacy claims must be supported per the Cosmetic Efficacy Claim Evaluation Specifications.
European Union：SCCS/1552/15 and subsequent opinions: face cream ≤2%, body lotion ≤0.5% (safe for simultaneous use); hydroquinone in products should be kept as low as possible and not exceed unavoidable trace levels (new study: LOQ 3 ppm / LOD 1 ppm); has been incorporated into the restricted substances list via regulatory amendment, effective February 1, 2025.
United States：CIR Expert Panel considers ≤2% safe for use.
Japan：Approved as a quasi-drug whitening active ingredient since 1989.
South Korea：Listed as a whitening ingredient; effective concentration 2.0–5.0%.
Australia：Face <2%, body <0.5%, with hydroquinone <10 mg/kg.
Taiwan, China：Arbutin limit 7%; impurity hydroquinone <20 ppm.
R&D Notes: Although China has no concentration limit, products exported to the EU must comply with the 2%/0.5% caps and hydroquinone content requirements; it is recommended that domestic products also proactively align with SCCS limits and hydroquinone control targets to reserve room for cross-border compliance.
Quality Standards and Testing Methods
When sourcing alpha-arbutin raw material, it is recommended to request the following items and test reports from suppliers:
Item | Reference Specification | Method |
|---|---|---|
Content (Purity) | ≥99.0% | HPLC |
Specific Optical Rotation | +175° ~ +185° | Polarimeter |
Hydroquinone | As low as possible (reference: SCCS raw material spec <0.01%; finished product LOQ 3 ppm) | HPLC |
Heavy Metals / Arsenic | <20 ppm / <2 ppm | ICP / Atomic Absorption |
Loss on Drying | ≤1.0% | 105 °C, 2 h |
For finished product hydroquinone testing, refer to the NMPA's 2023 revised Testing Methods for 4 Ingredients Including Alpha-Arbutin in Cosmetics.
Formulation Application Recommendations
Use Level: Reference the SCCS safety caps—face cream 0.5%–2%, body lotion ≤0.5%; efficacy claim concentrations should be determined based on human efficacy evaluation data.
pH Control: Maintain a weakly acidic to neutral pH (recommended formulation pH 5.0–6.5, within the ingredient's optimal range of 3.5–6.6); avoid strong acid or alkali conditions that could hydrolyze the glycosidic bond.
Temperature Control: Conventional emulsification processes (below 80 °C) are safe; the α-glycosidic bond has significantly better thermal stability than the β form; avoid prolonged high temperature combined with extreme pH.
Buffer System: Prioritize citrate buffer systems to suppress hydroquinone formation during storage (SCCS formulation experiments show a reduction of one order of magnitude).
Compatibility: Combination with niacinamide, vitamin C derivatives (e.g., 3-O-ethyl ascorbic acid), kojic acid, azelaic acid, tranexamic acid, etc., can achieve "inhibition of synthesis + accelerated metabolism" synergy; avoid direct combination with strong oxidizing systems; daily use requires sunscreen protection.
Claim Compliance: Skin-lightening products are managed as special cosmetics; efficacy claims must be supported by evaluation data.
Synthesis Process and Supply Chain
Alpha-arbutin is primarily produced via biocatalytic enzymatic synthesis: using hydroquinone and glucose (or a glucose donor) as substrates, α-glucosidase/sucrose phosphorylase catalyzes stereospecific glycosylation, followed by purification and crystallization to obtain high-purity product. The enzymatic route offers high α-configuration selectivity and few by-products, making it the current mainstream process; chemical synthesis routes suffer from poor selectivity and high purification costs. China is currently one of the world's major production bases for alpha-arbutin. On the supply side, key focus areas should include: configurational purity (optical rotation), batch-to-batch consistency of hydroquinone residue, and control of heavy metals and residual solvents.
FAQ
Q1: Which is better, alpha-arbutin or beta-arbutin?
Alpha-arbutin is approximately 10 times more potent than beta-arbutin in inhibiting tyrosinase, with superior thermal and pH stability and lower hydroquinone release risk—but at a higher cost.
Q2: Is alpha-arbutin safe? What is the appropriate use level?
SCCS considers ≤2% in face creams and ≤0.5% in body lotions safe; CIR considers ≤2% safe. It is recommended to reference this range and design use levels according to product type.
Q3: Does alpha-arbutin release hydroquinone?
Raw material grade data show that under normal storage conditions (25 °C/40 °C, 36 months), hydroquinone remains below 3 ppm; however, extreme conditions such as strong acid/alkali or prolonged high temperature may promote glycosidic hydrolysis. Formulations should control pH and temperature, with buffer systems added where necessary.
Q4: Is alpha-arbutin photosensitive? Can it be used during the day?
Published data show no risk of photocatalytic degradation (no hydroquinone detected after 12 months of sunlight exposure); as a whitening ingredient, daily use is still recommended with sunscreen.
Q5: Can alpha-arbutin be used with niacinamide?
Yes. Their mechanisms are complementary (inhibition of synthesis vs. blocking transport/accelerating metabolism), making them a common whitening combination.
References
[1] SCCS Opinion on the safety of alpha-arbutin and beta-arbutin in cosmetic products（SCCS/1552/15 及更新意见），European Commission
[2] 汉斯期刊：熊果苷作为化妆品美白功能因子的研究进展
[3] Funayama M, Arakawa H, Yamamoto R, et al. Effects of α- and β-arbutin on activity of tyrosinases from mushroom and mouse melanoma. Biosci Biotechnol Biochem. 1995;59(1):143-144.
[4] Sugimoto K, Nishimura T, Nomura K, et al. Inhibitory effects of α-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. Biol Pharm Bull. 2004;27(4):510-514.
[5] 2026 Formula Science Review：Alpha-Arbutin Formulation Science（行业综述）
[6] Verified Beauty Data：Alpha-arbutin 效力对比（Sugimoto 2003）